Top

04-08-2017 | Neuroendocrine tumors | Article

Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix

Journal: Annals of Surgical Oncology

Author: Eric K. Nakakura, MD, PhD

Publisher: Springer International Publishing

Abstract

Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst. 2012;104(10):764–77. doi:10.1093/jnci/djs208.CrossRefPubMed

Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46(6):715–31. doi:10.1097/MPA.0000000000000846.CrossRefPubMed

Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. (eds) AJCC cancer staging manual, 8th edn, New York: Springer; 2017.

Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, et al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 2015;39(5):683–90. doi:10.1097/PAS.0000000000000408.CrossRefPubMedPubMedCentral

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) , 7th edn. Chicago: Springer; 2010. p. 183–7.

Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012;41(6):840–4. doi:10.1097/MPA.0b013e31823cdaa0.CrossRefPubMed

Crippa S, Partelli S, Zamboni G, Scarpa A, Tamburrino D, Bassi C, et al. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. Surgery. 2014;155(1):145–53. doi:10.1016/j.surg.2013.08.002.CrossRefPubMed

Toste PA, Kadera BE, Tatishchev SF, Dawson DW, Clerkin BM, Muthusamy R, et al. Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival. J Gastrointest Surg. 2013;17(12):2105–13. doi:10.1007/s11605-013-2360-9.CrossRefPubMed

Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, et al. Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg. 2010;145(3):276–80. doi:10.1001/archsurg.2010.10.CrossRefPubMed

10.

Norlén O, Stålberg P, Öberg K, Eriksson J, Hedberg J, Hessman O, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg. 2012;36(6):1419–31. doi:10.1007/s00268-011-1296-z.CrossRefPubMed

11.

Wang SC, Fidelman N, Nakakura EK. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol. 2013;40(1):69–74. doi:10.1053/j.seminoncol.2012.11.007.CrossRefPubMed

12.

Bergsland EK, Nakakura EK. Neuroendocrine tumors of unknown primary: is the primary site really not known? JAMA Surg. 2014;149(9):889–90. doi:10.1001/jamasurg.2014.216.CrossRefPubMed

13.

Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol. 1987;5(10):1502–22.CrossRefPubMed

14.

Strosberg JR, Weber JM, Feldman M, Coppola D, Meredith K, Kvols LK. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors. J Clin Oncol. 2013;31(4):420–25. doi:10.1200/JCO.2012.44.5924.CrossRefPubMed

15.

www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf.

Medicine Matters Oncology

Abstract